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ABSTRACT
Background: Advancements in technology have allowed
laparoscopic surgery to expand into advanced procedures
such as liver resection; however, the value and safety of
laparoscopic liver surgery is still a topic for debate. This
study was designed to evaluate the feasibility and out-
come of laparoscopic nonanatomic hepatectomy using
the LigaSure device in a swine model.
Methods: Nonanatomic hepatic lobe resection was per-
formed in 3 groups comparing the open finger-fracture
method, the open method with the LigaSure device, and
the laparoscopic method with the LigaSure device. The
cut surfaces of the liver were evaluated for bleeding and
biliary leakage at the time of the operation. The animals
were inspected 48 hours later for hemorrhage and evalu-
ated with cholescintigraphy (hepatobiliary iminodiacetic
acid [HIDA] scan) for biliary leakage, in addition to histo-
logical evaluation of liver specimens.
Results: No hemorrhage or biliary leakage was noted in
the groups where the LigaSure device was used, whereas
1 animal from the open finger-fracture method sustained a
bile leak observed on HIDA scan. The operative blood
loss was considerably less in the groups where the Liga-
Sure device was used, and the shortest operative time was
observed in the laparoscopic group.
Conclusions: The LigaSure device can be safely and
effectively used to perform a laparoscopic nonanatomic
hepatectomy.
Key Words: Laparoscopy, Liver resection, LigaSure de-
vice.
INTRODUCTION
Laparoscopic surgery has enjoyed increasing success
since its modest beginning in 1983 and has become the
standard of care for cholecystectomy. Evaluation and ap-
plication of new technologies has allowed for the rapid
advancement of laparoscopic surgical techniques.1–4
What remains ill-defined is the application and safety of
laparoscopic surgery to complex solid-organ procedures
such as liver resection.5–7 The difficulties in approaching
laparoscopic liver surgery require continued improve-
ments in technology, such as video imaging, electrosurgi-
cal instruments, laparoscopic duplex ultrasound, and
greater success with bloodless surgery.8 One possible
application of advancements in laparoscopic liver surgery
is the performance of partial nonanatomic hepatectomy.
Using open surgical techniques, partial nonanatomic hep-
atectomy has gained acceptance as a procedure that may
be used to treat patients with hepatocellular carcinoma, as
well as other diagnoses.9,10 Nonanatomic liver resection is
technically demanding due to hepatic anatomic variability
and can be associated with considerable morbidity.11 In-
herent problems include bleeding and biliary leakage
from the cut surface of the liver.12
This study evaluated a new technique for liver resection
using the LigaSure electrosurgical vessel-sealing device
(Valleylab-Tyco Healthcare, Boulder, CO). The laparo-
scopic Atlas version of the device both seals and divides
blood vessels. It does so by combining energy control
with physical compression, including a brief cool down
that produces a distinctive, translucent seal of partially
denatured protein; thereby, fusing the collagen in the
vessel walls and occluding the lumen entirely.
These seals have bursting strengths comparable to those
of ligatures and, unlike clips, resist dislodgment because
they are intrinsic to the vessel wall structure. Thermal
spread is minimal and the autologous seals formed by the
LigaSure device can withstand 3x systolic pressure. The
LigaSure device may be used for sealing vessels up to 7
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SCIENTIFIC PAPERmm in diameter.13 It is used routinely at our institution for
laparoscopic living-donor nephrectomy. The effectiveness
of this device for liver resection is not known, but we
hypothesize that it has excellent potential for use in lapa-
roscopic nonanatomic liver resection. This series is our
initial experience with the LigaSure device in the perfor-
mance of laparoscopic nonanatomic resections of the liver
using a Sus scrofa pig model.
METHODS
The animal experiments were performed in accordance
with the 1996 National Research Council Guide for the
Care and Use of Laboratory Animals and applicable fed-
eral regulations. Preoperatively, the animals were fasted
12 hours and medicated with hydromorphone (0.1 mg/
kg), acepromazine (0.1 mg/kg), and glycopyrrolate (0.01
mg/kg intramuscularly). Anesthesia was induced with ti-
letamine/zolazepam (Telazol) (6 mg/kg intramuscularly).
The animals were then intubated and given xylazine (2
mg/kg intravenously), and anesthesia was maintained us-
ing isoflurane (1.5–3%). Monitoring of the anesthetized
animals was conducted using pulse oximetry for oxygen
saturation, end-tidal carbon dioxide sensors, and cardiac
sensors. The 9 domestic swine used in the experiments
weighed 29 kg to 36 kg and were divided equally into 3
groups. In all of the experiments, 60% to 80% of the left
lobe was removed. Before concluding each operation, all
groups of animals (I, II, and III) were visually inspected
for bleeding and biliary leakage at the site of resection. In
laparoscopic cases, pneumoperitoneum was released for
10 minutes prior to the final visual inspection. In all cases,
adequate hemostasis and biliary control was observed,
and the abdomen was closed in layers without drains. The
animals were weaned from anesthesia and extubated.
Postoperative analgesia for Groups I and II consisted of
morphine epidural (2 mg) placed between vertebrae L6
and S1 in addition to a transdermal fentanyl patch (75 g)
stapled to the animals’ posterior neck. Postoperative an-
algesia for Group III consisted of buprenorphine (0.01
mg/kg q 12 hours) and a transdermal fentanyl patch (75
g) stapled to the animals’ posterior neck. No antibiotics
were given postoperatively. Surgical details of liver resec-
tions were as follows:
Group I
The control animals underwent a nonanatomic left he-
patic lobectomy through a scalpel incision in the abdom-
inal midline by using the finger-fracture method. Blood
vessels and bile ducts were clipped or suture ligated as
appropriate and electrocautery (Bovie) was used where
indicated.
Group II
The animals in Group II underwent a nonanatomic left
hepatic lobectomy through a scalpel incision in the ab-
dominal midline. Division of the liver was accomplished
with electrocautery and Metzenbaum scissors. The Liga-
Sure device was used for sealing blood vessels and bile
ducts.
Group III
The animals in Group III underwent a laparoscopic, non-
anatomic, left hepatic lobectomy with the LigaSure device
for dividing the liver parenchyma and sealing and dividing
all blood vessels and bile ducts. The pneumoperitoneum
was insufflated by Veress needle and maintained at a
constant abdominal pressure of 12 mm Hg. Six ports were
used during the course of the procedure. A 10-mm trocar
placed 2cm below the umbilicus was used for camera
placement. The LigaSure device was introduced through a
10-mm trocar.
The laparoscopic Atlas version of the LigaSure was used to
divide the parenchyma as well as any vessels or bile ducts
in continuity without isolating them first. This was accom-
plished by opening the jaws of the device and then gently
applying pressure to the parenchymal surface. The device
was activated by depressing a foot pedal, and increasing
pressure applied to the handle, slowly approximating
(closing) the jaws. The rate of compression of the paren-
chyma was guided by the surgeon, who maintained a
1-mm blanched area of parenchyma around the jaws.
When the jaws of the device were approximated, indi-
cated by the handle locking, the device was “recycled,”
ensuring complete sealing of any vessel or duct within the
jaws. The excised segment of the liver was placed in an
endocatch bag, morselated, and removed through one of
the port-site incisions.
Animals from all groups (I, II, and III) were assessed for
biliary leakage on postoperative day 2 by cholescintigra-
phy. Animals were anesthetized with telazol (6 mg/kg
intramuscularly) to allow administration of the radiophar-
maceutical, Hepatolite (10 millicuries), given via a Jelco 22
gauge needle in the animals’ left lateral ear vein. One hour
later, a HIDA scan was performed using the ADAC Forte
camera, allowing evaluation of hepatocellular function
and patency of the hepatobiliary system by tracking the
production and flow of radiolabeled bile from the liver
through the bile ducts and into the intestine. Following
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inal incision for gross inspection of the cut surface of the
liver and the surrounding area for any evidence of hem-
orrhage or biliary leakage. Upon visual inspection, no
apparent evidence was present of biliary leakage, resolv-
ing hematoma, or abscess formation. Samples of the cut
surface were taken for histological examination, and the
animals were euthanized with a barbiturate overdose
(beuthanasia, 1 mL plus 1 mL/5 kg, intravenously). Sam-
ple tissue sections were then H and E stained.
Results were compared using the Mann-Whitney U test
for statistical significance. P0.05 was regarded as statis-
tically significant.
RESULTS
Intraoperative blood loss and operative times were signif-
icantly lower using the LigaSure device and are shown in
Table 1.
Survival in all 3 groups was 100%. Open resection animals
(Groups I and II) were depressed postoperatively, had
decreased appetite, and required analgesia. In contrast,
laparoscopic animals (Group III) were alert, responsive,
and feeding ad libitum 1 hour after recovery from anes-
thesia. Histological examination of excised liver and re-
maining liver at sacrifice showed secure sealing of all
biliary and vascular structures in the LigaSure groups. Not
unexpectedly, thermal injury from standard electrocautery
was 4 times greater than that observed in tissue examined
where the LigaSure device was used, as measured on
histological specimens.
One animal in Group I had a bile leak detected on HIDA
scan. However, this leak was not discernible upon subse-
quent visual inspection and was considered clinically in-
significant. No biliary leaks occurred in the LigaSure
groups identified by HIDA or visual inspection. Addition-
ally, postoperative bleeding was absent in all animals as
confirmed by gross inspection on postoperative Day 2.
DISCUSSION
Laparoscopic surgery provides benefits to the patients,
such as shorter recovery time, less pain, and more cos-
metically acceptable incisions. The surgeon may also ben-
efit due to improved visualization of anatomic detail.
However, solid visceral organs such as the liver pose a
significant challenge to the laparoscopic surgeon because
they have a soft parenchyma richly interspersed with
vasculature.14 Realization of the potential advantages of
laparoscopic liver resection requires the technical ability
to ensure hemostasis during division of the parenchyma.
The effectiveness of laparoscopic instrumentation in
maintaining a hemostatic, clear operative field has not
been well documented to date. Due to this fact, the ap-
plication of laparoscopic surgery to procedures on the
liver has been delayed by the lack of appropriate instru-
mentation, and the testing of laparoscopic surgical tech-
niques.
Greater acceptance of laparoscopic liver resection re-
quires careful evaluation of the safety and efficiency of
available technology and techniques. To date, laparo-
scopic liver resection has been evaluated in several case
studies demonstrating the expected benefits to patients:
decreased postoperative pain, reduced trauma to the ab-
dominal wall, smaller incisions, shorter hospital stay, and
earlier ambulation and return to normal activities com-
pared with conventional liver surgery.15–19
In this study, we evaluated the application of vessel-
sealing technology to liver resection in both open and
laparoscopic approaches. Our findings demonstrate effec-
tive sealing of intrahepatic blood vessels and bile ducts
without requiring isolation. Little to no blood loss oc-
curred using the LigaSure device as compared with that
with the standard finger-fracture method of partial hepa-
tectomy. Our specimens did not contain any veins greater
than 7 mm, and we believe that other methods, such as
endovascular staplers, would be required for larger portal
or hepatic vein branches.
A significant limitation of laparoscopic surgery, which has
prevented application to liver resection, is the difficulty in
controlling blood vessels. Laparoscopic suturing is diffi-
cult in the best circumstances; trying to control a bleeding
hepatic vein using laparoscopic suturing would be a for-
midable undertaking. The ability of the LigaSure device to
effectively seal intraparenchymal blood vessels is a signif-
icant advancement that increases the feasibility of laparo-
scopic liver resection. The additional finding that bile
ducts were effectively sealed further strengthens the ap-
plicability of the device to liver resection.
Table 1.
Intraoperative Blood Loss and Operative Times
Group I Group II Group III
Operative Time 65  5 minutes 40 minutes* 22  2 minutes†
Blood Loss 200  5m L 20 mL† 20 mL†
*P0.01.
†P0.001 vs Group I.
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resection in this study emphasizes the importance of new
surgical technology in extending the range of laparo-
scopic procedures available to the surgeon. There is no
question that liver resection, especially nonanatomic, is a
technically challenging operation. The application of lapa-
roscopic techniques to these procedures should be con-
sidered only where full support for advanced laparo-
scopic procedures is available, and by surgical teams
experienced in all aspects of liver surgery.
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